Dr. Anju Kaushal holds a PhD from Panjab University, Chandigarh, India, and has completed Quality Business courses from NZQ – NZ and the University of Auckland, extending her expertise in biologicals, therapeutics, and academia, particularly in the field of infectious diseases and microbiology. She has extensive experience in R&D, production, and quality assurance.
She has served as a Research Topic Coordinator for Frontiers in Antibiotics – Antibiotics in Clinical Use and as a Guest Editor (Primary) for the Journal of Medical Science. She has been recognized with the Best Researcher Award – Microbiology (Research Hypothesis Excellence) 2025 and was featured in the Marquis Who’s Who list for 2026–2029. Her research interests include vaccines, sera, diagnostics, and novel therapeutics, with a strong emphasis on healthcare, public health, and safety.
With more than 40 publications on LinkedIn and 21 peer-reviewed journal publications, she has participated in numerous international conferences and continues to contribute to research and innovation in microbiology, infectious diseases, and healthcare.